Contact this trialFirst, we need to learn more about you.
NA therapy
Stopping Antiviral Therapy for Chronic Hepatitis B
Recruiting1 award
San Francisco, California
This trial is for patients with the early antigen negative form of chronic hepatitis B who have been on antiviral drugs for at least 192 weeks. The trial offers the option to stop or continue treatment to see if there are any clinical differences and what the mechanisms and gene expression profiles are that correlate with the clinical course.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service